Sfoglia per AUTORE
PASSIGLIA F
Collezione AOU San Luigi di Orbassano

  

Items : 69

The evolving landscape of stage III unresectable non-small cell lung cancer "between lights and shadows". in Cancer treatment reviews / Cancer Treat Rev. 2025 Mar 11;135:102918. doi: 10.1016/j.ctrv.2025.102918.
2025
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ricardi U; Levis M; Capelletto E; Bironzo P; Merlini A; Reale ML; Ungaro A; Cani M; Garbo E; Napoli VM; Mogavero A; Saba G; Crespi V; Delcuratolo MD; Novello S; Passiglia F;

Metabolic Tumor Volume Assessed by 18F FDG-PET CT Scan as a Predictive Biomarker for Immune Checkpoint Blockers in Advanced NSCLC and Its Biological Correlates. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2025 Jan 17;31(2):352-364. doi: 10.1158/1078-0432.CCR-24-1993.
2025
AOU San Luigi di Orbassano

Dall'Olio FG; Zrafi W; Roelants V; Ambrosini V; Fourquet A; Mitea C; Passiglia F; Bauckneht M; Bonardel G; Conci N; Benitez JC; Arena V; Namour C; Naigeon M; Monnet I; Beshiri K; Hoton D; Dursun S; Danlos FX; Argalia G; Aldea M; Rovera G; Derosa L; Iebba V; Gietema HA; Gounant V; Lacroix V; Remon J; Gautheret D; et alii...

2025
AOU San Luigi di Orbassano
AOU Novara

Wakelee H; Garassino M; Peters S; Takada K; Naqash AR; Torri V; Hejleh TA; Ferrara R; Aerts JGJV; Aboubakar Nana F; Dingemans AM; Biello F; Rogado J; Moliner L; Beninato T; Lo Russo G; Servetto A; Mezquita L; Gorría T; Minuti G; Bennati C; Tonini G; Cortinovis DL; Agustoni F; Majem M; Baena J; Macerelli M; Monnet I; O'Reilly D; et alii...

MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database. in ESMO open / ESMO Open. 2024 Sep;9(9):103680. doi: 10.1016/j.esmoop.2024.103680. Epub 2024 Aug 29.
2024
ASL Asti
AOU San Luigi di Orbassano

Baldini E; Di Micco C; Banini M; Calvetti L; Leone F; Carta A; Pignataro D; Pozzessere D; Muscolino P; Bria E; Citarella F; Pilotto S; Cortinovis D; Gariazzo E; Pelizzari G; Roca E; Galetta D; Sini C; Delmonte A; Bulotta A; Occhipinti M; Minuti G; Cappuzzo F; Reale ML; Passiglia F; Favaretto A; Malapelle U; Novello S; Pasello G; et alii...

Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Nov;197:107990. doi: 10.1016/j.lungcan.2024.107990. Epub 2024 Oct 21.
2024
AOU San Luigi di Orbassano

Bertolaccini L; Tralongo AC; Del Re M; Facchinetti F; Ferrara R; Franchina T; Graziano P; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Cinquini M; Passiglia F; Novello S;

HER2-Altered Non-Small Cell Lung Cancer: A Journey from Current Approaches to Emerging Strategies. in Cancers / Cancers (Basel). 2024 May 26;16(11):2018. doi: 10.3390/cancers16112018.
2024
AOU San Luigi di Orbassano

Ferrari G; Del Rio B; Novello S; Passiglia F;

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Salerno F; Camerini A; Carta A; Follador A; Berardi R; Toschi L; Zoratto F; Cortinovis DL; Citarella F; Bulotta A; Rastelli F; Adamo V; Guida A; Manzo A; Cecere FL; Belluomini L; Roca E; Pasello G; Cerea G; Montrone M; Delcuratolo MD; Passiglia F; Guaitoli G; Bertolini F; Genova C; Caliman E; Mazzoni F; Siringo M; Gelibter A; et alii...

The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 May;191:107787. doi: 10.1016/j.lungcan.2024.107787. Epub 2024 Apr 5.
2024
AOU San Luigi di Orbassano

Malapelle U; Passiglia F; Pepe F; Pisapia P; Lucia Reale M; Cortinovis D; Fraggetta F; Galetta D; Garbo E; Graziano P; Pagni F; Pasello G; Piovano P; Pilotto S; Tiseo M; Genova C; Righi L; Troncone G; Novello S;

Niraparib plus Dostarlimab in Pleural Mesothelioma or Non-Small Cell Lung Cancer Harboring HRR Mutations: Interim Results of the UNITO-001 Phase II Prospective Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2024 Mar 1;30(5):959-964. doi: 10.1158/1078-0432.CCR-23-2431.
2024
AOU San Luigi di Orbassano

Passiglia F; Righi L; Bironzo P; Listì A; Farinea G; Capelletto E; Novello S; Merlini A; Scagliotti GV;

Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2024 Jan;187:107444. doi: 10.1016/j.lungcan.2023.107444. Epub 2023 Dec 15.
2024
ASL Alessandria
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Malapelle U; Novello S; Garbo E; Agustoni F; Gori S; Grisanti S; Catania C; Buffoni L; Buosi R; Brambilla M; Vavalà T; Scotti V; Carta A; Cerea G; Tiseo M; Delmonte A; Russo A; Cortinovis D; Chiari R; Metro G; Citarella F; Genova C; Roca E; Pilotto S; Bria E; Pelizzari G; Sini C; Galetta D; Bulotta A; et alii...

Actionable NSCLC Mutation Identification by Comprehensive Genomic Profiling for Clinical Trial Enrollment: The European Program for the Routine Testing of Patients With Advanced Lung Cancer (EPROPA). in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Dec 16:S1556-0864(24)02529-2. doi: 10.1016/j.jtho.2024.12.010.
2024
ASL Cuneo 2
ASL Asti
AOU San Luigi di Orbassano

Novello S; Scagliotti G; Righi L; Vallone S; Malapelle U; Volante M; Giannarelli D; Mohorcic K; Meoni G; Scotti V; Linardou H; Bettini AC; Ramizi KM; Secen N; Comanescu A; Felip E; Paz-Ares L; Pignataro D; Araujo A; Barbieri V; Mazilu L; Buffoni L; Taveggia PA; Simionato F; Roca E; Sini C; Tabbò F; Reale ML; Zambelli V; et alii...

Extracellular vesicles miR-574-5p and miR-181a-5p as prognostic markers in NSCLC patients treated with nivolumab. in Clinical and experimental medicine / Clin Exp Med. 2024 Aug 6;24(1):182. doi: 10.1007/s10238-024-01427-8.
2024
AOU San Luigi di Orbassano
AOU Novara

Gil-Bazo I; Baraibar I; Biello F; Rivoltini L; Chiari R; Baglivo S; Metro G; Passiglia F; Barletta G; Ludovini V; Rijavec E; Alama A; Dellepiane C; Dal Bello MG; Zullo L; Tagliamento M; Longo L; Vanni I; Rossi G; Ostano P; Santamaria S; Guana F; Chiorino G; Marconi S; Genova C; Novello S; Grossi F; Coco S;

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review. in Cancers / Cancers (Basel). 2023 Sep 28;15(19):4774. doi: 10.3390/cancers15194774.
2023
AOU San Luigi di Orbassano

Garbo E; Del Rio B; Ferrari G; Cani M; Napoli VM; Bertaglia V; Capelletto E; Rolfo C; Novello S; Passiglia F;

The Role of Germline Mutations in Thoracic Malignancies: Between Myth and Reality. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2023 Sep;18(9):1146-1164. doi: 10.1016/j.jtho.2023.05.028. Epub 2023 Jun 16.
2023
AOU San Luigi di Orbassano

Farinea G; Crespi V; Listì A; Righi L; Bironzo P; Merlini A; Malapelle U; Novello S; Scagliotti GV; Passiglia F;

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes. in Life (Basel, Switzerland) / Life (Basel). 2023 May 31;13(6):1291. doi: 10.3390/life13061291.
2023
AOU San Luigi di Orbassano

Mogavero A; Bironzo P; Righi L; Merlini A; Benso F; Novello S; Passiglia F;

Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies. in International journal of molecular sciences / Int J Mol Sci. 2023 May 17;24(10):8883. doi: 10.3390/ijms24108883.
2023
AOU San Luigi di Orbassano

Cani M; Napoli VM; Garbo E; Ferrari G; Del Rio B; Novello S; Passiglia F;

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2023 May;18(5):576-586. doi: 10.1016/j.jtho.2022.12.018. Epub 2023 Jan 13.
2023
AOU San Luigi di Orbassano

Aldea M; Marinello A; Duruisseaux M; Zrafi W; Conci N; Massa G; Metro G; Monnet I; Gomez Iranzo P; Tabbo F; Bria E; Guisier F; Vasseur D; Lindsay CR; Ponce-Aix S; Cousin S; Citarella F; Fallet V; Minatta JN; Eisert A; de Saint Basile H; Audigier-Valette C; Mezquita L; Calles A; Mountzios G; Tagliamento M; Remon Masip J; Raimbourg J; Terrisse S; et alii...

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours. in European respiratory review : an official journal of the European Respiratory Society / Eur Respir Rev. 2023 Feb 7;32(167):220174. doi: 10.1183/16000617.0174-2022. Print 2023 Mar 31.
2023
AOU San Luigi di Orbassano

Dumoulin DW; Bironzo P; Passiglia F; Scagliotti GV; Aerts JGJV;

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer? in EClinicalMedicine / EClinicalMedicine. 2023 Feb 6;57:101845. doi: 10.1016/j.eclinm.2023.101845. eCollection 2023 Mar.
2023
AOU San Luigi di Orbassano

Passiglia F; Novello S;

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.
2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Righi L; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M; Bironzo P; Scagliotti GV;

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Novello S; Gianetta M; Di Maio M; D'Amiano C; Capelletto E; Bianco V; Bertaglia V; Napoli VM; Leone G; Cecchi C; Audisio A; Turco F; Delcuratolo MD; Cetoretta V; Pisano C; Parlagreco E; Garbo E; Ferrari G; Del Rio B; Cani M; Persano I; Scagliotti GV; Bironzo P;

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib. in EBioMedicine / EBioMedicine. 2022 Sep;83:104213. doi: 10.1016/j.ebiom.2022.104213. Epub 2022 Aug 9.
2022
AOU San Luigi di Orbassano

Malapelle U; Passiglia F;

Optimizing diagnosis and treatment of EGFR exon 20 insertions mutant NSCLC. in Cancer treatment reviews / Cancer Treat Rev. 2022 Sep;109:102438. doi: 10.1016/j.ctrv.2022.102438. Epub 2022 Jul 18.
2022
AOU San Luigi di Orbassano

Passiglia F; Malapelle U; Normanno N; Pinto C;

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sangiolo D; Righi L; Passiglia F; Di Maio M; Paratore C; Bungaro M; De Filippis M; Consito L; Mecca C; Bertaglia V; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A; Novello S; Geuna M; Bironzo P;

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Oct;172:94-99. doi: 10.1016/j.lungcan.2022.08.008. Epub 2022 Aug 12.
2022
AOU San Luigi di Orbassano

Felip E; Smit EF; Molina-Vila MA; Dafni U; Massuti B; Berghmans T; de Marinis F; Passiglia F; Dingemans AC; Cobo M; Viteri S; Britschgi C; Cuffe S; Provencio M; Merkelbach-Bruse S; Andriakopoulou C; Kammler R; Ruepp B; Roschitzki-Voser H; Peters S; Wolf J; Stahel R;

Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort study. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Nov;11(11):2306-2317. doi: 10.21037/tlcr-22-667.
2022
AOU San Luigi di Orbassano

Zhang K; Zhou C; Gao J; Yu P; Lin X; Xie X; Liu M; Zhang J; Xie Z; Cui F; Li S; Passiglia F; Stella GM; Qin Y;

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.
2022
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Bertaglia V; Listì A; Garbo E; Scagliotti GV;

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery. in Biomedicines / Biomedicines. 2022 Mar 26;10(4):776. doi: 10.3390/biomedicines10040776.
2022
AOU San Luigi di Orbassano

Bungaro M; Passiglia F; Scagliotti GV;

Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Mar;11(3):381-392. doi: 10.21037/tlcr-22-168.
2022
AOU San Luigi di Orbassano

Tao H; Li F; Wu D; Ji S; Liu Q; Wang L; Liu B; Facchinetti F; Leong TL; Passiglia F; Hu Y;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.
2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Porzio G; Tiseo M; Russano M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Metro G; Migliorino MR; Passiglia F; Ricciardi S; Zoratto F; Pecci F; Di Marino P; Mansueto G; De Tursi M; Tuzi A; Gori S; Della Gravara L; Macerelli M; Rastelli F; Chiari R; Gelibter A; Marchetti P; Antonuzzo L; Mazzoni F; et alii...

Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jan;169:103536. doi: 10.1016/j.critrevonc.2021.103536. Epub 2021 Nov 18
2022
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; Seminati D; Pagni F; Parra HS; Migliorino MR; Rocco D; Troncone G; Novello S; Malapelle U; Pilotto S; Reale ML; Passiglia F; Pisapia P; Pepe F; Belluomini L; Galetta D; Cortinovis D; Tiseo M; Passaro A; et alii...

Targeting KRASp.G12C Mutation in Advanced Non-Small Cell Lung Cancer: a New Era Has Begun. in Current treatment options in oncology / Curr Treat Options Oncol. 2022 Dec;23(12):1699-1720. doi: 10.1007/s11864-022-01033-4. Epub 2022 Nov
2022
AOU San Luigi di Orbassano

Bungaro M; Novello S; Passiglia F;

Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP). in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2022 Dec;174:118-124. doi: 10.1016/j.lungcan.2022.11.005. Epub 2022 Nov 9.
2022
AOU San Luigi di Orbassano

Passaro A; Russo GL; Passiglia F; D'Arcangelo M; Sbrana A; Russano M; Bonanno L; Giusti R; Metro G; Bertolini F; Grisanti S; Carta A; Cecere F; Montrone M; Massa G; Perrone F; Simionato F; Guaitoli G; Scotti V; Genova C; Lugini A; Bonomi L; Attili I; de Marinis F;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU San Luigi di Orbassano

Passiglia F; Novello S; Buffoni L; Carnio S; Capelletto E; Zichi C; Reale ML; Artusio E; Olmetto E; Bungaro M; Paratore C; Bertaglia V; Audisio M; Rapetti SG; Pignataro D; Curcio H; De Luca E; Bironzo P; Tagliamento M; Scagliotti GV; Di Maio M;

The expanding family of c-Met inhibitors in solid tumors: a comparative analysis of their pharmacologic and clinical differences. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103602. doi: 10.1016/j.critrevonc.2022.103602. Epub 2022 Jan 19
2022
AOU San Luigi di Orbassano

Fogli S; Tabbò F; Capuano A; Del Re M; Passiglia F; Cucchiara F; Scavone C; Gori V; Novello S; Schmidinger M; Danesi R;

Winds From the ORIENT: New Data to Inform RATIONAL Choice? in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 Sep;16(9):1434-1436. doi: 10.1016/j.jtho.2021.07.003.
2021
AOU San Luigi di Orbassano

Bironzo P; Passiglia F; Novello S;

Repositioning PARP inhibitors in the treatment of thoracic malignancies. in Cancer treatment reviews / Cancer Treat Rev. 2021 Sep;99:102256. doi: 10.1016/j.ctrv.2021.102256. Epub 2021 Jul 7.
2021
AOU San Luigi di Orbassano

Passiglia F; Reale ML; Cetoretta V; Parlagreco E; Jacobs F; Listì A; Righi L; Bironzo P; Novello S; Scagliotti GV;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Bussolino F; Di Maio M; Righi L; Passiglia F; Listì A; Caglio A; Sperone T; Tabbò F; Reale ML; Bironzo P;

RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:74-83. doi: 10.1016/j.ejca.2021.01.015. Epub 2021 Feb 12.
2021
AOU San Luigi di Orbassano

Malapelle U; Passiglia F; Cremolini C; Reale ML; Pepe F; Pisapia P; Avallone A; Cortinovis D; De Stefano A; Fassan M; Fontanini G; Galetta D; Lauricella C; Listì A; Loupakis F; Pagni F; Pietrantonio F; Pilotto S; Righi L; Bianchi AS; Parra HS; Tiseo M; Verzè M; Troncone G; Novello S;

Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2876-2889. doi: 10.21037/tlcr-20-635.
2021
AOU San Luigi di Orbassano

Passiglia F; Cetoretta V; De Filippis M; Napoli V; Novello S;

Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2021 Jul;157:85-91. doi: 10.1016/j.lungcan.2021.05.009. Epub 2021 May 11.
2021
AOU San Luigi di Orbassano

Passiglia F; Leone G; Olmetto E; Delcuratolo MD; Tabbò F; Reale ML; Bertaglia V; Consito L; Bironzo P; Capelletto E; Novello S;

2021
AOU San Luigi di Orbassano

Passiglia F; Galvano A; Gristina V; Barraco N; Castiglia M; Perez A; La Mantia M; Russo A; Bazan V;

Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3191-3202. doi: 10.21037/tlcr-21-455.
2021
AOU San Luigi di Orbassano

Zhang X; Tian D; Chen Y; Chen C; He LN; Zhou Y; Li H; Lin Z; Chen T; Wang Y; Russo A; Nadal E; Passiglia F; Soo RA; Watanabe S; Moran T; Oh IJ; Fu S; Hong S; Zhang L;

Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All? in Current oncology reports / Curr Oncol Rep. 2021 Jan 2;23(1):10. doi: 10.1007/s11912-020-00989-6.
2021
AOU San Luigi di Orbassano

Tabbò F; Passiglia F; Novello S;

2021
AOU San Luigi di Orbassano

Scagliotti GV; Volante M; Novello S; Arizio F; Listì A; Righi L; Passiglia F; Bironzo P;

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103189. doi: 10.1016/j.critrevonc.2020.103189. Epub 2020 Nov 27
2021
AOU San Luigi di Orbassano

Sperone P; Capelletto E; Artusio E; Carnio S; Di Stefano RF; Rapetti S; Audisio M; Bungaro M; Tabbò F; Leone G; Mariniello A; Palesandro E; Bironzo P; Reale ML; Bertaglia V; Passiglia F; Novello S;

Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon. in Cancer treatment reviews / Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18.
2021
AOU San Luigi di Orbassano

Passiglia F; Bertaglia V; Reale ML; Delcuratolo MD; Tabbò F; Olmetto E; Capelletto E; Bironzo P; Novello S;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Di Maio M; Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A;

Benefits and Harms of Lung Cancer Screening by Chest Computed Tomography: A Systematic Review and Meta-Analysis. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2021 Aug 10;39(23):2574-2585. doi: 10.1200/JCO.20.02574. Epub 2021 Jun 2.
2021
AOU San Luigi di Orbassano

Ferrara R; Facchinetti F; Del Re M; Bertolaccini L; Cinquini M; Passiglia F; Franchina T; Larici AR; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Current treatment and future challenges in ROS1- and ALK-rearranged advanced non-small cell lung cancer. in Cancer treatment reviews / Cancer Treat Rev. 2021 Apr;95:102178. doi: 10.1016/j.ctrv.2021.102178. Epub 2021 Mar 10.
2021
AOU San Luigi di Orbassano

Remon J; Pignataro D; Novello S; Passiglia F;

Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Apr;160:103300. doi: 10.1016/j.critrevonc.2021.103300. Epub 2021 Mar 17
2021
AOU San Luigi di Orbassano

Malapelle U; Pilotto S; Passiglia F; Pepe F; Pisapia P; Righi L; Listì A; Bironzo P; Belluomini L; Tabbò F; Reale ML; Russo G; De Luca C; Novello S; Troncone G;

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Ficorella C; Porzio G; Cannita K; Addeo A; Banna GL; Friedlaender A; Spinelli GP; Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Ricciardi S; Migliorino MR; Landi L; Minuti G; Tuzi A; Bordi P; Russano M; Cantini L; Santini D; Citarella F; Zoratto F; Filetti M; Mansueto G; Di Marino P; Grassadonia A; Inno A; et alii...

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon? in ImmunoTargets and therapy / Immunotargets Ther. 2021 Feb 5;10:9-26. doi: 10.2147/ITT.S253581. eCollection 2021.
2021
AOU San Luigi di Orbassano

Passiglia F; Reale ML; Cetoretta V; Novello S;

KRAS inhibition in non-small cell lung cancer: Past failures, new findings and upcoming challenges. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Sep;137:57-68. doi: 10.1016/j.ejca.2020.06.023. Epub 2020 Jul 31.
2020
AOU San Luigi di Orbassano

Passiglia F; Malapelle U; Del Re M; Righi L; Pagni F; Furlan D; Danesi R; Troncone G; Novello S;

Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ? 50%: a multicenter study with external validation. in Journal for immunotherapy of cancer / J Immunother Cancer. 2020 Oct;8(2):e001403. doi: 10.1136/jitc-2020-001403.
2020
AOU San Luigi di Orbassano

Cortellini A; Ricciuti B; Tiseo M; Bria E; Banna GL; Aerts JG; Barbieri F; Giusti R; Cortinovis DL; Migliorino MR; Catino A; Passiglia F; Torniai M; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Gelibter A; Occhipinti MA; Rastelli F; Chiari R; Rocco D; Inno A; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Grossi F; et alii...

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ? 50% and Their Relationship With Clinical Outcomes. in Clinical lung cancer / Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21.
2020
AOU San Luigi di Orbassano

Cortellini A; Friedlaender A; Banna GL; Porzio G; Bersanelli M; Cappuzzo F; Aerts JGJV; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Berardi R; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Inno A; Di Marino P; Mansueto G; Zoratto F; et alii...

Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ??50. in Cancer immunology, immunotherapy : CII / Cancer Immunol Immunother. 2020 Nov;69(11):2209-2221. doi: 10.1007/s00262-020-02613-9. Epub 2020 May
2020
AOU San Luigi di Orbassano

Cortellini A; Tiseo M; Banna GL; Cappuzzo F; Aerts JGJV; Barbieri F; Giusti R; Bria E; Cortinovis D; Grossi F; Migliorino MR; Galetta D; Passiglia F; Santini D; Berardi R; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Tuzi A; Gelibter A; Marchetti P; Macerelli M; Rastelli F; Chiari R; Rocco D; Gori S; De Tursi M; et alii...

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.
2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baldessari C; Novello S; Bartoli G; Pizzutilo EG; Landi L; Dall'Olio FG; Toschi L; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Bearz A; Camerini A; Sala E; Migliorino MR; Cerea G; Ardizzoni A; Bennati C; Vita E; Del Conte A; Rossi S; Scotti V; Pilotto S; Cecere FL; Proto C; Berardi R; Mazzoni F; et alii...

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano

Remon J; Passiglia F; Ahn MJ; Barlesi F; Forde PM; Garon EB; Gettinger S; Goldberg SB; Herbst RS; Horn L; Kubota K; Lu S; Mezquita L; Paz-Ares L; Popat S; Schalper KA; Skoulidis F; Reck M; Adjei AA; Scagliotti GV;

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience. in Journal of thoracic disease / J Thorac Dis. 2020 Jul;12(7):3877-3882. doi: 10.21037/jtd.2020.03.76.
2020
AOU San Luigi di Orbassano

Capelletto E; Passiglia F; Ferraresi F; Vallone S; Novello S;

Treatment of advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102858. doi: 10.1016/j.critrevonc.2019.102858. Epub 2019 Dec 28
2020
AOU San Luigi di Orbassano

Rossi G; Ramella S; Passaro A; Menis J; Malapelle U; Franchina T; Ferrara R; Del Re M; Bertolaccini L; Facchinetti F; Pilotto S; Passiglia F; Trisolini R; Novello S;

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2518-2520. doi: 10.21037/tlcr-2019-cnsclc-14.
2020
AOU San Luigi di Orbassano

Passiglia F; Novello S;

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?-a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2020 Dec;9(6):2674-2685. doi: 10.21037/tlcr-20-710.
2020
AOU San Luigi di Orbassano

Leone G; Passiglia F; Bironzo P; Bertaglia V; Novello S;

Diagnosis and treatment of early and locally advanced non-small-cell lung cancer: The 2019 AIOM (Italian Association of Medical Oncology) clinical practice guidelines. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Apr;148:102862. doi: 10.1016/j.critrevonc.2019.102862. Epub 2020 Jan 25
2020
AOU San Luigi di Orbassano

Passiglia F; Bertolaccini L; Del Re M; Facchinetti F; Ferrara R; Franchina T; Malapelle U; Menis J; Passaro A; Pilotto S; Ramella S; Rossi G; Trisolini R; Novello S;

Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure? in Annals of translational medicine / Ann Transl Med. 2019 Sep;7(Suppl 6):S212. doi: 10.21037/atm.2019.08.91.
2019
AOU San Luigi di Orbassano

Bironzo P; Passiglia F; Novello S;

2019
AOU San Luigi di Orbassano

Facchinetti F; Pilotto S; Metro G; Baldini E; Bertolaccini L; Cappuzzo F; Delmonte A; Gasparini S; Inno A; Marchetti A; Passiglia F; Puma F; Ricardi U; Rossi A; Crinò L; Novello S;

Lung Cancer in Italy. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Dec;14(12):2046-2052. doi: 10.1016/j.jtho.2019.05.019.
2019
AOU San Luigi di Orbassano

Passiglia F; Calandri M; Guerrera F; Malapelle U; Mangone L; Ramella S; Trisolini R; Novello S;

First-line immune-chemotherapy combination: the right strategy to fight squamous non-small cell lung cancer? in Translational lung cancer research / Transl Lung Cancer Res. 2019 Aug;8(4):546-549. doi: 10.21037/tlcr.2019.04.05.
2019
AOU San Luigi di Orbassano

Passiglia F; Bironzo P; Scagliotti GV;

Immunotherapy in first line for extensive-stage small-cell lung cancer: another piece is going to fill the puzzle? in Annals of translational medicine / Ann Transl Med. 2018 Dec;6(Suppl 2):S120. doi: 10.21037/atm.2018.12.25.
2018
AOU San Luigi di Orbassano

Passiglia F; Novello S;